Hope W, McCulloch M W, Story D F, Rand M J
Eur J Pharmacol. 1977 Nov 15;46(2):101-11. doi: 10.1016/0014-2999(77)90245-x.
In the rabbit ear artery both dopamine and noradrenaline inhibit stimulation-induced (S-I) transmitter noradrenaline efflux. Pimozide, which is reported to be a specific dopamine receptor antagonist, was used to further study the effects of dopamine on transmitter efflux. In a concentration of 0.2 micrometer pimozide blocked the inhibition of S-I efflux produced by 0.5 micrometer dopamine but not that produced by 0.5 micrometer noradrenaline. In a concentration of 10 nM, pimozide enhances transmitter release and vasoconstrictor responses to sympathetic nerve stimulation; this may be due to blockade of feedback inhibition of transmitter release by endogenous dopamine. In a concentration of 1 micrometer, pimozide reduced transmitter release and vasoconstrictor responses to sympathetic nerve stimulation. Vasoconstrictor responses to noradrenaline and histamine are antagonized by pimozide in a noncompetitive manner.
在兔耳动脉中,多巴胺和去甲肾上腺素均抑制刺激诱导(S-I)的递质去甲肾上腺素外流。据报道,匹莫齐特是一种特异性多巴胺受体拮抗剂,被用于进一步研究多巴胺对递质外流的影响。浓度为0.2微摩尔时,匹莫齐特可阻断0.5微摩尔多巴胺对S-I外流的抑制作用,但不能阻断0.5微摩尔去甲肾上腺素所产生的抑制作用。浓度为10纳摩尔时,匹莫齐特可增强递质释放以及对交感神经刺激的血管收缩反应;这可能是由于内源性多巴胺对递质释放的反馈抑制被阻断所致。浓度为1微摩尔时,匹莫齐特可减少递质释放以及对交感神经刺激的血管收缩反应。匹莫齐特以非竞争性方式拮抗对去甲肾上腺素和组胺的血管收缩反应。